C0965390_NCI_NCI-GLOSS | Knowledge4COVID-19

Property	Value
?:definition	A drug used to reduce the amount of testosterone made in patients with advanced symptomatic prostate cancer for which no other treatment options are available. It belongs to the family of drugs called gonadotropin-releasing hormone (GnRH) antagonists.
?:hasCUIAnnotation	<https://research.tib.eu/covid-19/entity/C0965390>
?:hasGeneratedBy	<https://research.tib.eu/covid-19/SourceName/NCI_NCI-GLOSS>
?:type	<https://research.tib.eu/covid-19/vocab/AnnotationDefinition>

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/C0965390_NCI_NCI-GLOSS>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/C0965390_NCI_NCI-GLOSS>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all